ADPT - Adaptive Biotechnologies Corporation (ADPT) Q4 2023 Earnings Call Transcript
2024-02-14 21:51:03 ET
Adaptive Biotechnologies Corporation (ADPT)
Q4 2023 Earnings Conference Call
February 14, 2024 4:30 PM ET
Company Participants
Karina Calzadilla - Head, IR
Chad Robins - CEO and Co-founder
Tycho Peterson - CFO
Susan Bobulsky - Senior Vice President, Diagnostics, clonoSEQ
Sharon Benzeno - Chief Commercial Officer, Immune Medicine
Conference Call Participants
Dan Brennan - TD Cowen
David Westenberg - Piper Sandler
Mark Massaro - BTIG
Tejas Savant - Morgan Stanley
Andrew Brackmann - William Blair
Sung Ji Nam - Scotiabank
Elizabeth Webster - Goldman Sachs
Rachel Vatnsdal - JPMorgan
Presentation
Operator
Thank you for standing by and welcome to the Adaptive Biotechnologies Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question and answer session. [Operator Instructions]
As a reminder today’s program is being recorded. And now I’d like to introduce your host for today’s program, Karina Calzadilla, Head of Investor Relations. Please go ahead.
Karina Calzadilla
Thank you, Jonathan, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies fourth quarter and full year ‘23 earnings conference call. Earlier today, we issued a press release reporting Adaptive financial results for the fourth quarter and full year of ‘23. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and we’ll be referencing to a slide presentation that has been posted to the Investors section on our corporate website.
During the call, management will be making projections and other forward-looking statements within the meaning of federal securities laws regarding future events and the future financial performance of the Company. These statements reflect management’s current perspective of the business as of today. Actual results may differ materially from today’s forward-looking statements, depending on a number of factors, which are set forth in our public filings with the SEC and listed in this presentation. In addition, non-GAAP financial measures will be discussed during the call, and a reconciliation from non-GAAP to GAAP metrics can be found in our earnings release.
Joining the call today are Chad Robins, our CEO and Co-founder; and Tycho Peterson, our Chief Financial Officer. Additional members from management will be available for Q&A....
Adaptive Biotechnologies Corporation (ADPT) Q4 2023 Earnings Call Transcript